Navigation Links
Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test
Date:6/29/2011

NEW YORK and QUEBEC CITY, June 29, 2011 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc. (TSX: CUR), a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years.  This collaboration aims to maximize the commercialization of Previstage™ GCC Colorectal Cancer Staging Test, and further develop novel genomic cancer tests in the field of Personalized Medicine.

Under the definitive agreements underlying the collaboration, Signal Genetics is granted a worldwide exclusive license to the Previstage™ GCC Colorectal Cancer Staging Test developed by DiagnoCure, and acquires DiagnoCure's U.S. CLIA service laboratory. These two elements of the transaction combined are valued at a minimum of US$10.8M over five years, broken down into a US$5.7M upfront payment for the acquisition of DiagnoCure's U.S. laboratory, and a minimum of US$5.1M in annual installments and royalty payments over the first five years of the license agreement. In addition, Signal will pay DiagnoCure US$2.5M under an R&D agreement to advance the development of certain genomic tests being developed in its Quebec-based laboratories. All payments will be made in cash.

"Previstage™ GCC has been shown to offer key clinical information to improve colon cancer management and has an estimated global market potential of over US$400M," stated Joe Hernandez, CEO of Signal Genetics. "We are excited to add it to our product portfolio.  With our new subsidiary, CC Health LLC, we plan to expand our sales force and our marketing partnerships to sell the test nationwide.  Moreover, the R&D agreement provides Signal and its affiliates access to DiagnoCure's extensive experience in developing personalized genomic tests in oncology that are complementary technologies to the com
'/>"/>

SOURCE Signal Genetics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
2. Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area
3. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
4. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. Device Blocking Stomach Nerve Signals Shows Promise in Obesity
7. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
8. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
9. St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer
10. AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling
11. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Mass. , May 23, 2013  Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)...  MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... Oct. 28 Octapharma Group and Fresenius Kabi ... regarding the use of Fresenius Kabi,s HESylation® Technology ... the agreement, Fresenius Kabi will license its proprietary ... based on hydroxyethyl starch ("HES") which will be ...
... , MALVERN, Pa., Oct. 28 Featuring the lowest ... Siemens Healthcare,s SOMATOM® Definition Flash dual-source computed tomography (CT) ... for Children, Orlando, Fla., to better serve its pediatric ... of the radiation dose that systems previously required to ...
Cached Medicine Technology:Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 2Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 3Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 2Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 3
(Date:5/24/2013)... (PRWEB) May 24, 2013 ResortQuest Real ... joined the Dayna Feher team at the firm’s Bethany ... the Delaware resorts her home in 1975. Her real ... worked in all aspects of the real estate business ... the past 12 years, a licensed sales associate. ...
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group are ... than 59,229 complaints since 2004 from women claiming they suffered ... as the Mirena IUD.* , Among the most common of ... where the IUD came out on its own. There are ... article. “Abdominal pain is also common, with 3,774 complaints. And ...
(Date:5/24/2013)... (LA JOLLA, Calif.) (PRWEB) May 24, 2013 ... letter to House Appropriators and the California congressional ... them to restore sequestered industry user fees paid ... 2013, and to ensure that future across-the-board cuts ... as part of the FY14 Agriculture, Rural Development ...
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 Started in ... held in Orlando. 2013 marks AMTC’s 31st anniversary. SHINE ... family, starting with supermodel Millie Lewis and her daughter, Carey ... top agents, managers, casting directors, and music professionals including the ... Arts and XP Media. They are kings of Hollywood and ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... 30 Military Officers Association of America ... (Ret), pulled no punches in expressing MOAA,s objection to ... inpatient copays by $110 per day for retired servicemembers, family ... and extremely disappointed that there would be any copay increase ...
... at UCSF Medical Center have begun enrollment for an early-stage ... adult stem cell therapy for patients who have just experienced ... is part of a multi-center national study. The cells ... bone marrow of healthy adult donors. Depending on their location ...
... it lowered risk of neurological problems later , WEDNESDAY, Sept. ... body temperature of oxygen-deprived newborns reduces the risk for neurological ... risk of death or severe disability. , Still, the findings, ... England Journal of Medicine , help fill a crucial gap ...
... ... Jonathan Kraft , ... (Vocus) September 30, 2009 -- The Boston biotechnology industry will get an early look at ... October 27, 2009 at Harvard Medical School. , , ,At the one-day event, recently funded ...
... Simmons firm, a leading national law firm in the fight ... Miles for Meso 5K run/walk on Sunday, October 11, in ... www.milesformeso.org . , The Simmons firm ... in Alton, Ill. Nearly 500 runners and walkers registered, and ...
... DALLAS, Sept. 30 The Sleep Center at Baylor University ... American Academy of Sleep Medicine. The center at Baylor ... in North Texas. , "Accreditation provides formal recognition ... for patients suffering from sleep disorders," said David L. ...
Cached Medicine News:Health News:MOAA Decries 21% TRICARE Inpatient Copay Hike 2Health News:Cardiac stem cell trial seeks to treat some heart attack patients 2Health News:Cardiac stem cell trial seeks to treat some heart attack patients 3Health News:Cooling Helps Oxygen-Deprived Newborns 2Health News:Cooling Helps Oxygen-Deprived Newborns 3Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 2Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 3Health News:Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser 2Health News:Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation 2
... panel is designed for medical imaging. The 18 inch ... and ultrasound. It can be mounted on a wall ... It allows for RGB, s-video and composite inputs with ... in VGA input. In VGA mode, its resolution is ...
... fixation. Completely resorbable, it presented surgeons with ... the most thoroughly proven product of its ... with system enhancements that make it even ... system means that application of this proven ...
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... ultrasound A-scan Sonomed-315 is intended for visualization ... detection of midline shifts in the brain, ... and easy to use, the Sonomed-315 offers ... A-scanning mode allows to identify the anatomic ...
Medicine Products: